Article
Proteomic analysis provides insights into the molecular regulatory mechanism of Dengzhan Shengmai capsule in a rat model of vascular dementia
2022-08-09
Abstract excerpt
Dengzhan Shengmai (DZSM) capsule is a compound Chinese medicine that is widely used in the clinic for the treatment of ischemic cerebrovascular diseases along with symptoms of dementia and forgetfulness. DZSM can improve the cognitive function and quality of life of patients with vascular dementia (VD), but little is known about the therapeutic mechanisms. In this study, we found that DZSM rescued spatial memory i...
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Cerebrovascular and genetic disorders
- Genetic Associations and Epidemiology
- Mitochondrial Function and Pathology
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Nutritional Studies and Diet
- Tryptophan and brain disorders
Identifiers and source
- Literature Corpus work
- 39b4ebff-b473-5ba5-a5fe-fe2196214ddd
- DOI
- 10.21203/rs.3.rs-1931304/v1
